Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
30
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Johnson Karen Marie | Director | 12 | $40.0K | $0 | 2026-07-27 |
| Hively Brad | Director | 50 | $110.0K | $6.00M | 2026-07-27 |
| McGeorge Anne | Director | 10 | $0 | $0 | 2026-07-27 |
| TZOUMAKAS KIMBERLY JO | Director | 3 | $0 | $0 | 2026-07-27 |
| Kaushal Mohit | Director | 19 | $0 | $392.9K | 2026-07-27 |
| Pacala Mark L | Director | 16 | $99.7K | $200.0K | 2026-07-27 |
| STOLPER MARK | Director | 3 | $0 | $0 | 2026-07-27 |
| Chernett Jorey | 10% Owner | 15 | $2.61M | $0 | 2026-07-21 |
| Podnos Yale | Chief Medical Officer | 45 | $10.0K | $276.9K | 2026-07-14 |
| Carter Robert Ross | Chief Financial Officer | 14 | $10.0K | $879 | 2026-05-21 |
| Virnich Daniel | President | 37 | $25.0K | $7.6K | 2026-05-21 |
| England Kristin | Chief Administrative Officer | 2 | $0 | $0 | 2026-03-27 |
| Langsam Jeffrey | Chief Clinical Officer | 2 | $0 | $0 | 2026-03-27 |
| Ling Gabriel | Director | 6 | $0 | $0 | 2025-11-20 |
| TOI M, LLC | Director | 3 | $0 | $0 | 2025-11-18 |
| M33 Growth I GP LLC | Director, 10% Owner | 6 | $0 | $28.41M | 2025-09-04 |
| BARASCH RICHARD A | Director | 43 | $1.61M | $0 | 2025-07-24 |
| Castle Jeremy | Chief Operating Officer | 9 | $10.0K | $0 | 2025-05-21 |
| M33 Growth I L.P. | Director, 10% Owner | 2 | $0 | $0 | 2025-03-26 |
| Havencrest Healthcare Partners, L.P. | 10% Owner | 37 | $0 | $5.11M | 2024-08-16 |
| Shah Mihir | Chief Financial Officer | 12 | $127.0K | $0 | 2024-05-21 |
| TOI HC I, LLC | 10% Owner | 24 | $0 | $3.48M | 2024-01-23 |
| Havencrest Healthcare Partners GP, LLC | 10% Owner | 11 | $0 | $1.90M | 2023-12-28 |
| O'Meara Maeve | Director | 5 | $0 | $0 | 2023-12-26 |
| Miller Matthew P | Chief Operating Officer | 13 | $70.0K | $1.2K | 2023-03-17 |
| SARIN RAVI YANG | Director | 7 | $0 | $0 | 2023-03-17 |
| Simoneit Diona | Chief Accounting Officer | 4 | $0 | $386 | 2022-11-17 |
| Jimmy Holdings, Inc. | 10% Owner | 3 | $0 | $11.14M | 2022-06-10 |
| Dalgleish Scott | Chief Financial Officer | 7 | $0 | $0 | 2022-03-21 |
| OncologyCare Partners, LLC | Director | 1 | $0 | $0 | 2021-11-12 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Johnson Karen Marie | Director | A Award | 2026-07-27 | 2026-07-29 | 31,124 | — | $0 | 319,410 | SEC↗ |
| Hively Brad | Director | A Award | 2026-07-27 | 2026-07-29 | 27,108 | — | $0 | 710,829 | SEC↗ |
| TZOUMAKAS KIMBERLY JO | Director | A Award | 2026-07-27 | 2026-07-29 | 29,116 | — | $0 | 46,301 | SEC↗ |
| STOLPER MARK | Director | A Award | 2026-07-27 | 2026-07-29 | 31,124 | — | $0 | 56,957 | SEC↗ |
| Pacala Mark L | Director | A Award | 2026-07-27 | 2026-07-29 | 30,120 | — | $0 | 286,881 | SEC↗ |
| McGeorge Anne | Director | A Award | 2026-07-27 | 2026-07-29 | 41,165 | — | $0 | 332,535 | SEC↗ |
| Kaushal Mohit | Director | A Award | 2026-07-27 | 2026-07-29 | 33,133 | — | $0 | 205,716 | SEC↗ |
| Pacala Mark L | Director | A Award | 2026-07-27 | 2026-07-29 | 30,120 | — | $0 | 286,881 | SEC↗ |
| STOLPER MARK | Director | A Award | 2026-07-27 | 2026-07-29 | 31,124 | — | $0 | 56,957 | SEC↗ |
| TZOUMAKAS KIMBERLY JO | Director | A Award | 2026-07-27 | 2026-07-29 | 29,116 | — | $0 | 46,301 | SEC↗ |
| McGeorge Anne | Director | A Award | 2026-07-27 | 2026-07-29 | 41,165 | — | $0 | 332,535 | SEC↗ |
| Kaushal Mohit | Director | A Award | 2026-07-27 | 2026-07-29 | 33,133 | — | $0 | 205,716 | SEC↗ |
| Johnson Karen Marie | Director | A Award | 2026-07-27 | 2026-07-29 | 31,124 | — | $0 | 319,410 | SEC↗ |
| Hively Brad | Director | A Award | 2026-07-27 | 2026-07-29 | 27,108 | — | $0 | 710,829 | SEC↗ |
| Chernett Jorey | 10% Owner | P Buy | 2026-07-21 | 2026-07-22 | 18,000 | $5.27 | $94.9K | 10,648,858 | SEC↗ |
| Podnos Yale | Chief Medical Officer | M Exercise deriv | 2026-07-14 | 2026-07-16 | 5,478 | $2.00 | $11.0K | 0 | SEC↗ |
| Podnos Yale | Chief Medical Officer | M Exercise deriv | 2026-07-14 | 2026-07-16 | 17,974 | $1.87 | $33.6K | 0 | SEC↗ |
| Podnos Yale | Chief Medical Officer | M Exercise | 2026-07-14 | 2026-07-16 | 17,974 | $1.87 | $33.6K | 277,501 | SEC↗ |
| Podnos Yale | Chief Medical Officer | S Sale | 2026-07-14 | 2026-07-16 | 17,974 | $6.43 | $115.6K | 259,527 | SEC↗ |
| Podnos Yale | Chief Medical Officer | S Sale | 2026-07-14 | 2026-07-16 | 5,478 | $6.35 | $34.8K | 259,527 | SEC↗ |
| Podnos Yale | Chief Medical Officer | M Exercise | 2026-07-14 | 2026-07-16 | 5,478 | $2.00 | $11.0K | 265,005 | SEC↗ |
| Chernett Jorey | 10% Owner | P Buy | 2026-07-10 | 2026-07-13 | 15,000 | $5.85 | $87.8K | 10,630,858 | SEC↗ |
| STOLPER MARK | Director | A Award | 2026-07-07 | 2026-07-09 | 25,833 | — | $0 | 25,833 | SEC↗ |
| TZOUMAKAS KIMBERLY JO | Director | A Award | 2026-07-07 | 2026-07-09 | 17,185 | — | $0 | 17,185 | SEC↗ |
| Chernett Jorey | 10% Owner | P Buy | 2026-06-23 | 2026-06-24 | 18,000 | $5.02 | $90.4K | 10,615,858 | SEC↗ |
| Podnos Yale | Chief Medical Officer | S Sale | 2026-06-08 | 2026-06-09 | 23,451 | $5.38 | $126.2K | 259,527 | SEC↗ |
| Chernett Jorey | 10% Owner | P Buy | 2026-06-04 | 2026-06-05 | 12,000 | $4.75 | $57.0K | 10,579,858 | SEC↗ |
| Carter Robert Ross | Chief Financial Officer | J Other | 2026-05-21 | 2026-05-22 | 1,604 | $4.47 | $7.2K | 414,801 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | J Other | 2026-05-21 | 2026-05-22 | 23,058 | $4.47 | $103.1K | 2,337,166 | SEC↗ |
| Podnos Yale | Chief Medical Officer | J Other | 2026-05-21 | 2026-05-22 | 1,805 | $4.47 | $8.1K | 282,978 | SEC↗ |
| Chernett Jorey | 10% Owner | P Buy | 2026-05-20 | 2026-05-21 | 33,500 | $4.07 | $136.3K | 10,567,858 | SEC↗ |
| Chernett Jorey | 10% Owner | P Buy | 2026-05-19 | 2026-05-20 | 30,000 | $4.09 | $122.7K | 10,529,358 | SEC↗ |
| Chernett Jorey | 10% Owner | P Buy | 2026-05-19 | 2026-05-21 | 5,000 | $4.05 | $20.3K | 10,534,358 | SEC↗ |
| Kaushal Mohit | Director | S Sale | 2026-04-16 | 2026-04-16 | 38,433 | $3.50 | $134.5K | 172,583 | SEC↗ |
| Kaushal Mohit | Director | S Sale | 2026-04-14 | 2026-04-16 | 57,286 | $3.50 | $200.5K | 211,016 | SEC↗ |
| Chernett Jorey | 10% Owner | P Buy | 2026-04-09 | 2026-04-13 | 20,000 | $3.10 | $62.0K | 10,499,358 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | J Other | 2026-03-27 | 2026-04-01 | 98,534 | $3.07 | $302.5K | 2,360,224 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | A Award | 2026-03-27 | 2026-04-01 | 670,608 | — | $0 | 2,458,758 | SEC↗ |
| Carter Robert Ross | Chief Financial Officer | J Other | 2026-03-27 | 2026-04-01 | 20,320 | $3.07 | $62.4K | 416,405 | SEC↗ |
| Carter Robert Ross | Chief Financial Officer | A Award | 2026-03-27 | 2026-04-01 | 202,914 | — | $0 | 436,725 | SEC↗ |
| Podnos Yale | Chief Medical Officer | J Other | 2026-03-27 | 2026-04-01 | 16,173 | $3.07 | $49.7K | 284,783 | SEC↗ |
| Podnos Yale | Chief Medical Officer | A Award | 2026-03-27 | 2026-04-01 | 66,446 | — | $0 | 300,956 | SEC↗ |
| England Kristin | Chief Administrative Officer | A Award | 2026-03-27 | 2026-04-01 | 55,743 | — | $0 | 153,780 | SEC↗ |
| Langsam Jeffrey | Chief Clinical Officer | A Award | 2026-03-27 | 2026-04-01 | 70,270 | — | $0 | 127,650 | SEC↗ |
| Chernett Jorey | 10% Owner | P Buy | 2026-03-27 | 2026-03-30 | 27,429 | $2.96 | $81.2K | 10,479,358 | SEC↗ |
| Chernett Jorey | 10% Owner | P Buy | 2026-03-26 | 2026-03-27 | 50,000 | $3.15 | $157.5K | 10,451,929 | SEC↗ |
| Chernett Jorey | 10% Owner | P Buy | 2026-03-24 | 2026-03-25 | 125,000 | $3.11 | $388.8K | 10,401,929 | SEC↗ |
| Chernett Jorey | 10% Owner | P Buy | 2026-03-20 | 2026-03-23 | 25,000 | $3.35 | $83.8K | 10,276,929 | SEC↗ |
| Chernett Jorey | 10% Owner | P Buy | 2026-03-17 | 2026-03-17 | 75,000 | $3.42 | $256.5K | 10,251,929 | SEC↗ |
| Podnos Yale | Chief Medical Officer | J Other | 2026-03-17 | 2026-03-18 | 3,420 | $3.59 | $12.3K | 234,510 | SEC↗ |
| Carter Robert Ross | Chief Financial Officer | J Other | 2026-03-17 | 2026-03-18 | 1,314 | $3.59 | $4.7K | 233,811 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | J Other | 2026-03-17 | 2026-03-18 | 11,834 | $3.59 | $42.5K | 1,788,150 | SEC↗ |
| Chernett Jorey | 10% Owner | P Buy | 2026-03-16 | 2026-03-17 | 60,985 | $3.29 | $200.6K | 10,176,929 | SEC↗ |
| Chernett Jorey | 10% Owner | P Buy | 2026-03-13 | 2026-03-17 | 263,000 | $2.92 | $768.0K | 10,115,944 | SEC↗ |
| Carter Robert Ross | Chief Financial Officer | S Sale | 2026-01-02 | 2026-01-05 | 247 | $3.56 | $879 | 235,122 | SEC↗ |
| Carter Robert Ross | Chief Financial Officer | J Other | 2026-01-02 | 2026-01-06 | 244 | $3.67 | $895 | 235,125 | SEC↗ |
| Hively Brad | Director | S Sale | 2025-12-15 | 2025-12-16 | 13,333 | $3.77 | $50.3K | 683,721 | SEC↗ |
| Hively Brad | Director | A Award | 2025-11-20 | 2025-11-24 | 41,667 | — | $0 | 664,647 | SEC↗ |
| Hively Brad | Director | A Award | 2025-11-20 | 2025-11-24 | 32,407 | — | $0 | 697,054 | SEC↗ |
| Pacala Mark L | Director | A Award | 2025-11-20 | 2025-11-24 | 46,296 | — | $0 | 221,267 | SEC↗ |
| Pacala Mark L | Director | A Award | 2025-11-20 | 2025-11-24 | 35,494 | — | $0 | 256,761 | SEC↗ |
| Johnson Karen Marie | Director | A Award | 2025-11-20 | 2025-11-24 | 47,840 | — | $0 | 251,249 | SEC↗ |
| Johnson Karen Marie | Director | A Award | 2025-11-20 | 2025-11-24 | 37,037 | — | $0 | 288,286 | SEC↗ |
| Ling Gabriel | Director | A Award | 2025-11-20 | 2025-11-24 | 46,296 | — | $0 | 296,502 | SEC↗ |
| Ling Gabriel | Director | A Award | 2025-11-20 | 2025-11-24 | 37,037 | — | $0 | 333,539 | SEC↗ |
| Kaushal Mohit | Director | A Award | 2025-11-20 | 2025-11-24 | 50,926 | — | $0 | 228,179 | SEC↗ |
| Kaushal Mohit | Director | A Award | 2025-11-20 | 2025-11-24 | 40,123 | — | $0 | 268,302 | SEC↗ |
| McGeorge Anne | Director | A Award | 2025-11-20 | 2025-11-24 | 40,123 | — | $0 | 291,370 | SEC↗ |
| McGeorge Anne | Director | A Award | 2025-11-20 | 2025-11-24 | 67,901 | — | $0 | 251,247 | SEC↗ |
| Ling Gabriel | Director | J Other | 2025-11-18 | 2025-11-20 | 141,149 | — | $0 | 250,206 | SEC↗ |
| TOI M, LLC | Director | J Other | 2025-11-18 | 2025-11-20 | 11,818 | — | $0 | 7,944,207 | SEC↗ |
| TOI M, LLC | Director | J Other | 2025-11-18 | 2025-11-20 | 590,892 | — | $0 | 0 | SEC↗ |
| TOI M, LLC | Director | J Other | 2025-11-18 | 2025-11-20 | 2,500,000 | — | $0 | 5,444,207 | SEC↗ |
| Pacala Mark L | Director | S Sale | 2025-11-18 | 2025-11-20 | 1,210 | $4.00 | $4.8K | 221,601 | SEC↗ |
| Pacala Mark L | Director | S Sale | 2025-11-18 | 2025-11-20 | 2,160 | $4.00 | $8.6K | 222,811 | SEC↗ |
| Pacala Mark L | Director | S Sale | 2025-11-18 | 2025-11-20 | 46,630 | $4.00 | $186.5K | 174,971 | SEC↗ |
| Carter Robert Ross | Chief Financial Officer | A Award | 2025-11-17 | 2025-11-19 | 195 | — | $0 | 235,369 | SEC↗ |
| Podnos Yale | Chief Medical Officer | A Award | 2025-11-17 | 2025-11-19 | 2,086 | — | $0 | 237,930 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | A Award | 2025-11-17 | 2025-11-19 | 6,464 | — | $0 | 1,799,984 | SEC↗ |
| Podnos Yale | Chief Medical Officer | A Award | 2025-11-12 | 2025-11-14 | 1,202 | — | $0 | 235,844 | SEC↗ |
| Podnos Yale | Chief Medical Officer | A Award | 2025-11-12 | 2025-11-14 | 306 | — | $0 | 234,642 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | A Award | 2025-11-12 | 2025-11-14 | 6,211 | — | $0 | 1,793,520 | SEC↗ |
| M33 Growth I GP LLC | Director, 10% Owner | S Sale | 2025-09-04 | 2025-09-05 | 6,018,168 | $3.09 | $18.60M | 7,932,389 | SEC↗ |
| M33 Growth I GP LLC | Director, 10% Owner | S Sale | 2025-09-04 | 2025-09-05 | 681,832 | $3.09 | $2.11M | 590,892 | SEC↗ |
| Hively Brad | Director | S Sale | 2025-08-19 | 2025-08-21 | 20,221 | $4.06 | $82.1K | 622,980 | SEC↗ |
| BARASCH RICHARD A | Director | J Other | 2025-07-24 | 2025-07-28 | 287,756 | — | $0 | 2,635,881 | SEC↗ |
| England Kristin | Chief Administrative Officer | A Award | 2025-07-22 | 2025-07-24 | 98,037 | — | $0 | 98,037 | SEC↗ |
| BARASCH RICHARD A | Director | C Conversion deriv | 2025-06-18 | 2025-06-20 | 6,204 | — | $0 | 0 | SEC↗ |
| BARASCH RICHARD A | Director | C Conversion | 2025-06-18 | 2025-06-20 | 620,400 | — | $0 | 2,555,541 | SEC↗ |
| BARASCH RICHARD A | Director | C Conversion deriv | 2025-06-17 | 2025-06-20 | 1,595 | — | $0 | 0 | SEC↗ |
| BARASCH RICHARD A | Director | X Exercise deriv | 2025-06-17 | 2025-06-24 | 679,224 | — | $0 | 0 | SEC↗ |
| BARASCH RICHARD A | Director | C Conversion | 2025-06-17 | 2025-06-20 | 159,500 | — | $0 | 1,935,141 | SEC↗ |
| BARASCH RICHARD A | Director | X Exercise | 2025-06-17 | 2025-06-24 | 679,224 | $1.20 | $815.1K | 3,234,765 | SEC↗ |
| BARASCH RICHARD A | Director | F Tax w/h | 2025-06-17 | 2025-06-24 | 311,128 | $2.62 | $815.2K | 2,923,637 | SEC↗ |
| M33 Growth I GP LLC | Director, 10% Owner | S Sale | 2025-06-05 | 2025-06-09 | 76,324 | $3.05 | $232.8K | 1,272,724 | SEC↗ |
| M33 Growth I GP LLC | Director, 10% Owner | S Sale | 2025-06-05 | 2025-06-09 | 673,676 | $3.05 | $2.05M | 13,950,557 | SEC↗ |
| Hively Brad | Director | M Exercise deriv | 2025-06-03 | 2025-06-05 | 684,528 | — | $0 | 0 | SEC↗ |
| Hively Brad | Director | M Exercise deriv | 2025-06-03 | 2025-06-05 | 105,320 | — | $0 | 0 | SEC↗ |
| Hively Brad | Director | M Exercise deriv | 2025-06-03 | 2025-06-05 | 131,297 | — | $0 | 0 | SEC↗ |
| Hively Brad | Director | M Exercise deriv | 2025-06-03 | 2025-06-05 | 946,460 | — | $0 | 0 | SEC↗ |
| Hively Brad | Director | M Exercise | 2025-06-03 | 2025-06-05 | 684,528 | $0.85 | $581.8K | 1,396,561 | SEC↗ |
| Hively Brad | Director | M Exercise | 2025-06-03 | 2025-06-05 | 105,320 | $0.48 | $50.6K | 1,501,881 | SEC↗ |
| Hively Brad | Director | M Exercise | 2025-06-03 | 2025-06-05 | 131,297 | $1.87 | $245.5K | 1,633,178 | SEC↗ |
| Hively Brad | Director | M Exercise | 2025-06-03 | 2025-06-05 | 946,460 | $0.85 | $804.5K | 2,579,638 | SEC↗ |
| Hively Brad | Director | S Sale | 2025-06-03 | 2025-06-05 | 1,867,605 | $2.87 | $5.36M | 712,033 | SEC↗ |
| Hively Brad | Director | S Sale | 2025-06-03 | 2025-06-05 | 108,532 | $2.87 | $311.5K | 603,501 | SEC↗ |
| Castle Jeremy | Chief Operating Officer | D To issuer | 2025-05-21 | 2025-05-22 | 5,636 | $2.68 | $15.1K | 247,031 | SEC↗ |
| Carter Robert Ross | Chief Financial Officer | D To issuer | 2025-05-21 | 2025-05-22 | 1,601 | $2.68 | $4.3K | 235,174 | SEC↗ |
| Podnos Yale | Chief Medical Officer | D To issuer | 2025-05-21 | 2025-05-22 | 1,801 | $2.68 | $4.8K | 234,336 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | D To issuer | 2025-05-21 | 2025-05-22 | 20,388 | $2.68 | $54.6K | 1,787,309 | SEC↗ |
| Langsam Jeffrey | Chief Clinical Officer | A Award | 2025-05-21 | 2025-05-23 | 57,380 | — | $0 | 57,380 | SEC↗ |
| M33 Growth I GP LLC | Director, 10% Owner | S Sale | 2025-05-20 | 2025-05-22 | 203,532 | $2.71 | $551.6K | 1,349,048 | SEC↗ |
| M33 Growth I GP LLC | Director, 10% Owner | S Sale | 2025-05-20 | 2025-05-22 | 1,796,468 | $2.71 | $4.87M | 14,624,233 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | A Award | 2025-03-31 | 2025-04-02 | 1,083,334 | — | $0 | 1,807,697 | SEC↗ |
| Castle Jeremy | Chief Operating Officer | A Award | 2025-03-31 | 2025-04-02 | 162,281 | — | $0 | 252,667 | SEC↗ |
| Carter Robert Ross | Chief Financial Officer | A Award | 2025-03-31 | 2025-04-02 | 197,368 | — | $0 | 236,775 | SEC↗ |
| Podnos Yale | Chief Medical Officer | A Award | 2025-03-31 | 2025-04-02 | 157,088 | — | $0 | 236,137 | SEC↗ |
| Hively Brad | Director | P Buy deriv | 2025-03-26 | 2025-04-28 | 22,640 | $0.13 | $2.9K | 22,640 | SEC↗ |
| Hively Brad | Director | P Buy | 2025-03-26 | 2025-04-28 | 45,280 | $1.04 | $47.1K | 712,033 | SEC↗ |
| BARASCH RICHARD A | Director | P Buy deriv | 2025-03-26 | 2025-03-28 | 679,224 | $0.13 | $88.3K | 679,224 | SEC↗ |
| Carter Robert Ross | Chief Financial Officer | P Buy deriv | 2025-03-26 | 2025-03-28 | 4,528 | $0.13 | $589 | 4,528 | SEC↗ |
| Castle Jeremy | Chief Operating Officer | P Buy deriv | 2025-03-26 | 2025-03-28 | 4,528 | $0.13 | $589 | 4,528 | SEC↗ |
| Hively Brad | Director | P Buy deriv | 2025-03-26 | 2025-03-28 | 4,528 | $0.13 | $589 | 4,528 | SEC↗ |
| Johnson Karen Marie | Director | P Buy deriv | 2025-03-26 | 2025-03-28 | 18,112 | $0.13 | $2.4K | 18,112 | SEC↗ |
| Pacala Mark L | Director | P Buy deriv | 2025-03-26 | 2025-03-28 | 42,281 | $0.13 | $5.5K | 42,281 | SEC↗ |
| Podnos Yale | Chief Medical Officer | P Buy deriv | 2025-03-26 | 2025-03-28 | 4,528 | $0.13 | $589 | 4,528 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | P Buy deriv | 2025-03-26 | 2025-03-28 | 11,320 | $0.13 | $1.5K | 11,320 | SEC↗ |
| M33 Growth I L.P. | Director, 10% Owner | A Award deriv | 2025-03-26 | 2025-03-28 | 1,358,449 | $0.13 | $176.6K | 1,358,449 | SEC↗ |
| BARASCH RICHARD A | Director | P Buy | 2025-03-26 | 2025-03-28 | 1,358,448 | $1.04 | $1.41M | 1,775,641 | SEC↗ |
| Carter Robert Ross | Chief Financial Officer | P Buy | 2025-03-26 | 2025-03-28 | 9,056 | $1.04 | $9.4K | 39,407 | SEC↗ |
| Castle Jeremy | Chief Operating Officer | P Buy | 2025-03-26 | 2025-03-28 | 9,056 | $1.04 | $9.4K | 90,386 | SEC↗ |
| Hively Brad | Director | P Buy | 2025-03-26 | 2025-03-28 | 9,056 | $1.04 | $9.4K | 675,809 | SEC↗ |
| Johnson Karen Marie | Director | P Buy | 2025-03-26 | 2025-03-28 | 36,224 | $1.04 | $37.7K | 203,409 | SEC↗ |
| Pacala Mark L | Director | P Buy | 2025-03-26 | 2025-03-28 | 90,562 | $1.04 | $94.2K | 224,971 | SEC↗ |
| Podnos Yale | Chief Medical Officer | P Buy | 2025-03-26 | 2025-03-28 | 9,056 | $1.04 | $9.4K | 79,049 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | P Buy | 2025-03-26 | 2025-03-28 | 22,640 | $1.04 | $23.5K | 724,363 | SEC↗ |
| M33 Growth I L.P. | Director, 10% Owner | A Award | 2025-03-26 | 2025-03-28 | 2,716,898 | $1.04 | $2.83M | 16,420,701 | SEC↗ |
| Carter Robert Ross | Chief Financial Officer | D To issuer | 2025-03-19 | 2025-03-20 | 1,150 | $0.89 | $1.0K | 30,351 | SEC↗ |
| Podnos Yale | Chief Medical Officer | D To issuer | 2025-03-19 | 2025-03-20 | 2,975 | $0.89 | $2.6K | 69,993 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | D To issuer | 2025-03-19 | 2025-03-20 | 10,261 | $0.89 | $9.1K | 701,723 | SEC↗ |
| Carter Robert Ross | Chief Financial Officer | D To issuer | 2025-01-06 | 2025-01-07 | 258 | $0.34 | $88 | 31,501 | SEC↗ |
| Castle Jeremy | Chief Operating Officer | D To issuer | 2024-12-03 | 2024-12-05 | 1,130 | $0.16 | $181 | 81,330 | SEC↗ |
| Hively Brad | Director | P Buy | 2024-12-02 | 2024-12-02 | 50,000 | $0.15 | $7.5K | 666,753 | SEC↗ |
| Hively Brad | Director | P Buy | 2024-11-26 | 2024-12-02 | 250,000 | $0.17 | $42.5K | 616,753 | SEC↗ |
| Hively Brad | Director | A Award | 2024-11-22 | 2024-11-25 | 44,000 | — | $0 | 720,203 | SEC↗ |
| Ling Gabriel | Director | A Award | 2024-11-22 | 2024-11-25 | 40,000 | — | $0 | 109,057 | SEC↗ |
| Kaushal Mohit | Director | A Award | 2024-11-22 | 2024-11-25 | 56,000 | — | $0 | 177,253 | SEC↗ |
| Johnson Karen Marie | Director | A Award | 2024-11-22 | 2024-11-25 | 52,000 | — | $0 | 167,185 | SEC↗ |
| McGeorge Anne | Director | A Award | 2024-11-22 | 2024-11-25 | 56,000 | — | $0 | 183,346 | SEC↗ |
| Pacala Mark L | Director | A Award | 2024-11-22 | 2024-11-25 | 50,000 | — | $0 | 134,409 | SEC↗ |
| BARASCH RICHARD A | Director | A Award | 2024-11-22 | 2024-11-25 | 80,000 | — | $0 | 417,193 | SEC↗ |
| Podnos Yale | Chief Medical Officer | D To issuer | 2024-11-20 | 2024-11-21 | 267 | $0.14 | $37 | 73,994 | SEC↗ |
| Podnos Yale | Chief Medical Officer | D To issuer | 2024-11-20 | 2024-11-21 | 1,026 | $0.14 | $144 | 72,968 | SEC↗ |
| Podnos Yale | Chief Medical Officer | D To issuer | 2024-11-20 | 2024-11-21 | 1,709 | $0.14 | $239 | 74,261 | SEC↗ |
| Carter Robert Ross | Chief Financial Officer | D To issuer | 2024-11-20 | 2024-11-21 | 235 | $0.14 | $33 | 31,759 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | D To issuer | 2024-11-20 | 2024-11-21 | 4,750 | $0.14 | $665 | 716,961 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | D To issuer | 2024-11-20 | 2024-11-21 | 4,977 | $0.14 | $697 | 711,984 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | J Other | 2024-11-12 | 2024-11-18 | 78,094 | — | $0 | 838,853 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | J Other | 2024-11-12 | 2024-11-18 | 117,142 | — | $0 | 721,711 | SEC↗ |
| Pacala Mark L | Director | J Other | 2024-11-12 | 2024-11-18 | 30,372 | — | $0 | 84,409 | SEC↗ |
| Pacala Mark L | Director | J Other | 2024-11-12 | 2024-11-18 | 20,248 | — | $0 | 114,781 | SEC↗ |
| Podnos Yale | Chief Medical Officer | J Other | 2024-11-12 | 2024-11-18 | 17,039 | — | $0 | 75,970 | SEC↗ |
| Podnos Yale | Chief Medical Officer | J Other | 2024-11-12 | 2024-11-18 | 11,359 | — | $0 | 93,009 | SEC↗ |
| Hively Brad | Director | J Other | 2024-11-12 | 2024-12-02 | 353,450 | — | $0 | 366,753 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | J Other | 2024-08-16 | 2024-08-20 | 8,701,823 | — | $0 | 7,884,044 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | J Other | 2024-08-16 | 2024-08-20 | 7,631,418 | — | $0 | 252,626 | SEC↗ |
| Hively Brad | Director | D To issuer | 2024-06-17 | 2024-06-20 | 18,121 | $0.46 | $8.3K | 676,203 | SEC↗ |
| Hively Brad | Director | D To issuer | 2024-05-22 | 2024-05-23 | 19,526 | $0.58 | $11.3K | 694,324 | SEC↗ |
| Castle Jeremy | Chief Operating Officer | A Award deriv | 2024-05-21 | 2024-05-23 | 175,299 | — | $0 | 175,299 | SEC↗ |
| Podnos Yale | Chief Medical Officer | A Award deriv | 2024-05-21 | 2024-05-23 | 43,825 | — | $0 | 43,825 | SEC↗ |
| Shah Mihir | Chief Financial Officer | A Award deriv | 2024-05-21 | 2024-05-23 | 378,648 | — | $0 | 378,648 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | A Award deriv | 2024-05-21 | 2024-05-23 | 496,293 | — | $0 | 496,293 | SEC↗ |
| Castle Jeremy | Chief Operating Officer | A Award | 2024-05-21 | 2024-05-23 | 70,120 | — | $0 | 82,460 | SEC↗ |
| Podnos Yale | Chief Medical Officer | A Award | 2024-05-21 | 2024-05-23 | 17,530 | — | $0 | 104,368 | SEC↗ |
| Shah Mihir | Chief Financial Officer | A Award | 2024-05-21 | 2024-05-23 | 151,459 | — | $0 | 474,931 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | A Award | 2024-05-21 | 2024-05-23 | 198,517 | — | $0 | 916,947 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | D To issuer | 2024-05-21 | 2024-05-23 | 11,173 | $0.60 | $6.7K | 718,430 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2024-01-29 | 2024-01-30 | 8,637 | $2.12 | $18.3K | 0 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2024-01-26 | 2024-01-26 | 6,979 | $2.14 | $14.9K | 8,637 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2024-01-25 | 2024-01-26 | 11,882 | $2.07 | $24.6K | 15,616 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2024-01-24 | 2024-01-26 | 24,915 | $2.30 | $57.3K | 27,498 | SEC↗ |
| TOI HC I, LLC | 10% Owner | S Sale | 2024-01-23 | 2024-01-23 | 5,338 | $2.11 | $11.3K | 52,413 | SEC↗ |
| TOI HC I, LLC | 10% Owner | S Sale | 2024-01-22 | 2024-01-23 | 10,263 | $2.12 | $21.8K | 57,751 | SEC↗ |
| TOI HC I, LLC | 10% Owner | S Sale | 2024-01-19 | 2024-01-23 | 11,986 | $2.13 | $25.5K | 68,014 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | J Other | 2023-12-28 | 2024-01-02 | 3,999,998 | — | $0 | 8,881,823 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | J Other | 2023-12-28 | 2024-01-02 | 4,561,050 | — | $0 | 12,801,821 | SEC↗ |
| Pacala Mark L | Director | A Award | 2023-12-26 | 2023-12-28 | 46,630 | — | $0 | 135,029 | SEC↗ |
| O'Meara Maeve | Director | A Award | 2023-12-26 | 2023-12-28 | 50,000 | — | $0 | 109,104 | SEC↗ |
| McGeorge Anne | Director | A Award | 2023-12-26 | 2023-12-28 | 56,000 | — | $0 | 127,346 | SEC↗ |
| Ling Gabriel | Director | A Award | 2023-12-26 | 2023-12-28 | 40,000 | — | $0 | 69,057 | SEC↗ |
| Kaushal Mohit | Director | A Award | 2023-12-26 | 2023-12-28 | 53,326 | — | $0 | 121,253 | SEC↗ |
| Johnson Karen Marie | Director | A Award | 2023-12-26 | 2023-12-28 | 52,000 | — | $0 | 115,185 | SEC↗ |
| Hively Brad | Director | A Award | 2023-12-26 | 2023-12-28 | 42,652 | — | $0 | 713,850 | SEC↗ |
| BARASCH RICHARD A | Director | A Award | 2023-12-26 | 2023-12-28 | 80,000 | — | $0 | 337,193 | SEC↗ |
| Shah Mihir | Chief Financial Officer | P Buy | 2023-12-14 | 2023-12-18 | 99,435 | $1.27 | $126.3K | 327,557 | SEC↗ |
| Shah Mihir | Chief Financial Officer | P Buy | 2023-12-14 | 2023-12-18 | 565 | $1.25 | $706 | 328,122 | SEC↗ |
| Castle Jeremy | Chief Operating Officer | A Award deriv | 2023-11-30 | 2023-12-04 | 30,849 | — | $0 | 30,849 | SEC↗ |
| Castle Jeremy | Chief Operating Officer | A Award | 2023-11-30 | 2023-12-04 | 12,340 | — | $0 | 12,340 | SEC↗ |
| Podnos Yale | Chief Medical Officer | D To issuer | 2023-11-21 | 2023-11-22 | 1,530 | $2.19 | $3.4K | 86,838 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | D To issuer | 2023-11-21 | 2023-11-22 | 4,322 | $2.19 | $9.5K | 729,603 | SEC↗ |
| Hively Brad | Director | D To issuer | 2023-11-21 | 2023-11-22 | 25,867 | $2.19 | $56.6K | 671,198 | SEC↗ |
| Hively Brad | Director | M Exercise deriv | 2023-11-17 | 2023-11-21 | 25,000 | — | $0 | 1,745,431 | SEC↗ |
| Hively Brad | Director | M Exercise | 2023-11-17 | 2023-11-21 | 25,000 | $0.85 | $21.3K | 722,065 | SEC↗ |
| Hively Brad | Director | S Sale | 2023-11-17 | 2023-11-21 | 25,000 | $2.24 | $56.0K | 697,065 | SEC↗ |
| Hively Brad | Director | D To issuer | 2023-11-14 | 2023-11-15 | 27,117 | $2.39 | $64.8K | 697,065 | SEC↗ |
| Virnich Daniel | Chief Executive Officer | D To issuer | 2023-11-14 | 2023-11-16 | 4,604 | $2.39 | $11.0K | 733,925 | SEC↗ |
| Podnos Yale | Chief Medical Officer | D To issuer | 2023-11-14 | 2023-11-16 | 1,860 | $2.39 | $4.4K | 88,368 | SEC↗ |
| Podnos Yale | Chief Medical Officer | D To issuer | 2023-11-14 | 2023-11-16 | 238 | $2.39 | $569 | 90,228 | SEC↗ |
| Hively Brad | Director | M Exercise deriv | 2023-11-13 | 2023-11-15 | 47,000 | — | $0 | 1,770,431 | SEC↗ |
| Hively Brad | Director | M Exercise | 2023-11-13 | 2023-11-15 | 47,000 | $0.85 | $40.0K | 771,182 | SEC↗ |
| Hively Brad | Director | S Sale | 2023-11-13 | 2023-11-15 | 47,000 | $2.52 | $118.4K | 724,182 | SEC↗ |
| Shah Mihir | Chief Financial Officer | D To issuer | 2023-05-23 | 2023-05-24 | 2,573 | $0.43 | $1.1K | 224,341 | SEC↗ |
| Shah Mihir | Chief Financial Officer | D To issuer | 2023-05-23 | 2023-05-24 | 869 | $0.43 | $374 | 223,472 | SEC↗ |
| Hively Brad | Chief Executive Officer | A Award deriv | 2023-03-17 | 2023-03-21 | 421,280 | — | $0 | 421,280 | SEC↗ |
| Virnich Daniel | President | A Award deriv | 2023-03-17 | 2023-03-21 | 287,361 | — | $0 | 287,361 | SEC↗ |
| Miller Matthew P | Chief Operating Officer | A Award deriv | 2023-03-17 | 2023-03-21 | 169,169 | — | $0 | 169,169 | SEC↗ |
| Shah Mihir | Chief Financial Officer | A Award deriv | 2023-03-17 | 2023-03-21 | 440,477 | — | $0 | 440,477 | SEC↗ |
| Podnos Yale | Chief Medical Officer | A Award deriv | 2023-03-17 | 2023-03-21 | 83,047 | — | $0 | 83,047 | SEC↗ |
| Hively Brad | Chief Executive Officer | A Award | 2023-03-17 | 2023-03-21 | 168,512 | — | $0 | 724,182 | SEC↗ |
| Johnson Karen Marie | Director | A Award | 2023-03-17 | 2023-03-21 | 19,685 | — | $0 | 63,185 | SEC↗ |
| Pacala Mark L | Director | A Award | 2023-03-17 | 2023-03-21 | 6,562 | — | $0 | 88,399 | SEC↗ |
| McGeorge Anne | Director | A Award | 2023-03-17 | 2023-03-21 | 26,247 | — | $0 | 71,346 | SEC↗ |
| O'Meara Maeve | Director | A Award | 2023-03-17 | 2023-03-21 | 16,404 | — | $0 | 59,104 | SEC↗ |
| Virnich Daniel | President | A Award | 2023-03-17 | 2023-03-21 | 114,944 | — | $0 | 738,529 | SEC↗ |
| SARIN RAVI YANG | Director | A Award | 2023-03-17 | 2023-03-21 | 29,528 | — | $0 | 75,427 | SEC↗ |
| Miller Matthew P | Chief Operating Officer | A Award | 2023-03-17 | 2023-03-21 | 67,667 | — | $0 | 242,992 | SEC↗ |
| Shah Mihir | Chief Financial Officer | A Award | 2023-03-17 | 2023-03-21 | 176,191 | — | $0 | 226,914 | SEC↗ |
| BARASCH RICHARD A | Director | P Buy | 2023-03-17 | 2023-03-21 | 52 | $0.55 | $29 | 217,245 | SEC↗ |
| BARASCH RICHARD A | Director | P Buy | 2023-03-17 | 2023-03-21 | 7,654 | $0.55 | $4.2K | 235,047 | SEC↗ |
| BARASCH RICHARD A | Director | P Buy | 2023-03-17 | 2023-03-21 | 10,000 | $0.55 | $5.5K | 217,193 | SEC↗ |
| BARASCH RICHARD A | Director | P Buy | 2023-03-17 | 2023-03-21 | 9,948 | $0.55 | $5.5K | 227,393 | SEC↗ |
| BARASCH RICHARD A | Director | P Buy | 2023-03-17 | 2023-03-21 | 200 | $0.55 | $110 | 217,445 | SEC↗ |
| BARASCH RICHARD A | Director | P Buy | 2023-03-17 | 2023-03-21 | 10,000 | $0.55 | $5.5K | 257,193 | SEC↗ |
| BARASCH RICHARD A | Director | P Buy | 2023-03-17 | 2023-03-21 | 10,000 | $0.55 | $5.5K | 247,193 | SEC↗ |
| BARASCH RICHARD A | Director | P Buy | 2023-03-17 | 2023-03-21 | 2,146 | $0.55 | $1.2K | 237,193 | SEC↗ |
| Podnos Yale | Chief Medical Officer | A Award | 2023-03-17 | 2023-03-21 | 33,219 | — | $0 | 90,466 | SEC↗ |
| Kaushal Mohit | Director | A Award | 2023-03-17 | 2023-03-21 | 19,685 | — | $0 | 42,393 | SEC↗ |
| Miller Matthew P | Chief Operating Officer | P Buy | 2022-12-16 | 2022-12-20 | 73,684 | $0.95 | $70.0K | 175,325 | SEC↗ |
| Virnich Daniel | President | M Exercise deriv | 2022-12-07 | 2022-12-08 | 175,000 | — | $0 | 829,609 | SEC↗ |
| Virnich Daniel | President | M Exercise deriv | 2022-12-07 | 2022-12-08 | 175,000 | — | $0 | 654,609 | SEC↗ |
| Virnich Daniel | President | M Exercise | 2022-12-07 | 2022-12-08 | 175,000 | $0.86 | $150.5K | 623,585 | SEC↗ |
| Virnich Daniel | President | M Exercise | 2022-12-07 | 2022-12-08 | 175,000 | $0.86 | $150.5K | 448,585 | SEC↗ |
| Hively Brad | Chief Executive Officer | A Award deriv | 2022-11-17 | 2022-11-21 | 525,188 | — | $0 | 525,188 | SEC↗ |
| Miller Matthew P | Chief Operating Officer | A Award deriv | 2022-11-17 | 2022-11-21 | 119,825 | — | $0 | 119,825 | SEC↗ |
| Podnos Yale | Chief Medical Officer | A Award deriv | 2022-11-17 | 2022-11-21 | 71,895 | — | $0 | 71,895 | SEC↗ |
| Shah Mihir | Chief Financial Officer | A Award deriv | 2022-11-17 | 2022-11-21 | 94,418 | — | $0 | 94,418 | SEC↗ |
| Simoneit Diona | Chief Accounting Officer | A Award deriv | 2022-11-17 | 2022-11-21 | 52,722 | — | $0 | 52,722 | SEC↗ |
| Virnich Daniel | President | A Award deriv | 2022-11-17 | 2022-11-21 | 203,543 | — | $0 | 203,543 | SEC↗ |
| BARASCH RICHARD A | Director | A Award | 2022-11-17 | 2022-11-21 | 22,708 | — | $0 | 164,727 | SEC↗ |
| Hively Brad | Chief Executive Officer | A Award | 2022-11-17 | 2022-11-21 | 103,469 | — | $0 | 555,670 | SEC↗ |
| Johnson Karen Marie | Director | A Award | 2022-11-17 | 2022-11-21 | 22,708 | — | $0 | 43,500 | SEC↗ |
| Kaushal Mohit | Director | A Award | 2022-11-17 | 2022-11-21 | 22,708 | — | $0 | 48,242 | SEC↗ |
| Ling Gabriel | Director | A Award | 2022-11-17 | 2022-11-21 | 29,057 | — | $0 | 29,057 | SEC↗ |
| McGeorge Anne | Director | A Award | 2022-11-17 | 2022-11-21 | 22,708 | — | $0 | 45,099 | SEC↗ |
| Miller Matthew P | Chief Operating Officer | A Award | 2022-11-17 | 2022-11-21 | 23,607 | — | $0 | 101,641 | SEC↗ |
| O'Meara Maeve | Director | A Award | 2022-11-17 | 2022-11-21 | 22,708 | — | $0 | 42,700 | SEC↗ |
| Pacala Mark L | Director | A Award | 2022-11-17 | 2022-11-21 | 2,160 | — | $0 | 52,780 | SEC↗ |
| Pacala Mark L | Director | A Award | 2022-11-17 | 2022-11-21 | 29,057 | — | $0 | 81,837 | SEC↗ |
| Podnos Yale | Chief Medical Officer | A Award | 2022-11-17 | 2022-11-21 | 14,164 | — | $0 | 57,247 | SEC↗ |
| SARIN RAVI YANG | Director | A Award | 2022-11-17 | 2022-11-21 | 22,708 | — | $0 | 45,899 | SEC↗ |
| Shah Mihir | Chief Financial Officer | A Award | 2022-11-17 | 2022-11-21 | 18,602 | — | $0 | 50,723 | SEC↗ |
| Simoneit Diona | Chief Accounting Officer | A Award | 2022-11-17 | 2022-11-21 | 10,387 | — | $0 | 39,705 | SEC↗ |
| Virnich Daniel | President | A Award | 2022-11-17 | 2022-11-21 | 40,101 | — | $0 | 273,585 | SEC↗ |
| BARASCH RICHARD A | Director | A Award | 2022-11-17 | 2022-12-30 | 65,174 | — | $0 | 207,193 | SEC↗ |
| Hively Brad | Chief Executive Officer | D To issuer | 2022-11-15 | 2022-11-17 | 9,718 | $2.03 | $19.7K | 452,201 | SEC↗ |
| Miller Matthew P | Chief Operating Officer | D To issuer | 2022-11-15 | 2022-11-17 | 577 | $2.03 | $1.2K | 78,034 | SEC↗ |
| Podnos Yale | Chief Medical Officer | D To issuer | 2022-11-15 | 2022-11-17 | 199 | $2.03 | $404 | 43,083 | SEC↗ |
| Simoneit Diona | Chief Accounting Officer | D To issuer | 2022-11-15 | 2022-11-17 | 190 | $2.03 | $386 | 29,318 | SEC↗ |
| Virnich Daniel | President | D To issuer | 2022-11-15 | 2022-11-17 | 3,767 | $2.03 | $7.6K | 233,484 | SEC↗ |
| Hively Brad | Chief Executive Officer | S Sale | 2022-11-15 | 2022-11-22 | 9,718 | $2.03 | $19.7K | 452,201 | SEC↗ |
| Miller Matthew P | Chief Operating Officer | S Sale | 2022-11-15 | 2022-11-22 | 577 | $2.03 | $1.2K | 78,034 | SEC↗ |
| Podnos Yale | Chief Medical Officer | S Sale | 2022-11-15 | 2022-11-22 | 199 | $2.03 | $404 | 43,083 | SEC↗ |
| Simoneit Diona | Chief Accounting Officer | S Sale | 2022-11-15 | 2022-11-22 | 190 | $2.03 | $386 | 29,318 | SEC↗ |
| Virnich Daniel | President | S Sale | 2022-11-15 | 2022-11-22 | 3,767 | $2.03 | $7.6K | 233,484 | SEC↗ |
| Kaushal Mohit | Director | S Sale | 2022-11-14 | 2022-11-15 | 15,994 | $2.13 | $34.1K | 25,534 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-11-11 | 2022-11-15 | 365,321 | $2.33 | $851.2K | 13,362,873 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-11-10 | 2022-11-10 | 61,281 | $2.98 | $182.6K | 13,728,194 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-11-09 | 2022-11-10 | 80,000 | $3.09 | $247.2K | 13,789,475 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-11-08 | 2022-11-10 | 27,000 | $3.24 | $87.5K | 13,869,475 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-11-07 | 2022-11-07 | 19,167 | $3.28 | $62.9K | 13,896,475 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-11-04 | 2022-11-07 | 50,200 | $3.39 | $170.2K | 13,915,642 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-11-03 | 2022-11-07 | 45,500 | $3.58 | $162.9K | 13,965,842 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-11-02 | 2022-11-02 | 58,500 | $3.94 | $230.5K | 14,011,342 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-11-01 | 2022-11-02 | 50,272 | $4.26 | $214.2K | 14,069,842 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-10-31 | 2022-11-02 | 41,855 | $4.69 | $196.3K | 14,120,114 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-10-28 | 2022-10-28 | 52,091 | $4.84 | $252.1K | 14,161,969 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-10-27 | 2022-10-28 | 35,000 | $5.09 | $178.2K | 14,214,060 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-10-26 | 2022-10-28 | 52,500 | $5.16 | $270.9K | 14,249,060 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-10-25 | 2022-10-25 | 30,400 | $5.10 | $155.0K | 14,301,560 | SEC↗ |
| Kaushal Mohit | Director | S Sale | 2022-10-24 | 2022-10-25 | 4,798 | $4.96 | $23.8K | 41,528 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-10-24 | 2022-10-25 | 29,400 | $4.98 | $146.4K | 14,331,960 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-10-21 | 2022-10-25 | 20,000 | $4.96 | $99.2K | 14,361,360 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-10-20 | 2022-10-20 | 12,000 | $4.83 | $58.0K | 14,381,360 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-10-19 | 2022-10-20 | 17,500 | $4.68 | $81.9K | 14,393,360 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-10-18 | 2022-10-20 | 12,200 | $4.63 | $56.5K | 14,410,860 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-10-17 | 2022-10-17 | 8,249 | $4.60 | $37.9K | 14,423,060 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-10-14 | 2022-10-17 | 9,800 | $4.54 | $44.5K | 14,431,309 | SEC↗ |
| Havencrest Healthcare Partners | 10% Owner | S Sale | 2022-10-13 | 2022-10-17 | 25,200 | $4.67 | $117.7K | 14,441,109 | SEC↗ |
| TOI HC I, LLC | 10% Owner | S Sale | 2022-10-12 | 2022-10-12 | 14,343 | $4.70 | $67.4K | 14,466,309 | SEC↗ |
| TOI HC I, LLC | 10% Owner | S Sale | 2022-10-11 | 2022-10-12 | 25,000 | $4.66 | $116.5K | 14,480,652 | SEC↗ |